Mirum Pharmaceuticals, Inc.

MIRM · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$222,503$286,326$28,003$31,340
Short-Term Investments$57,812$0$123,716$125,201
Receivables$78,286$67,968$23,994$3,267
Inventory$22,403$22,312$5,565$1,513
Other Curr. Assets$11,784$10,935$8,947$5,271
Total Curr. Assets$392,788$387,541$190,225$166,592
Property Plant & Equip (Net)$9,814$1,990$2,345$2,550
Goodwill$0$0$0$0
Intangibles$249,819$252,925$58,954$18,740
Long-Term Investments$12,526$0$0$4,983
Tax Assets$0$0$0$0
Other NC Assets$5,807$4,165$101,382$101,786
Total NC Assets$277,966$259,080$162,681$128,059
Other Assets$0$0$0$0
Total Assets$670,754$646,621$352,906$294,651
Liabilities
Payables$14,618$7,416$8,690$9,166
Short-Term Debt$1,709$1,104$931$711
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$110,224$78,544$55,108$32,719
Total Curr. Liab.$126,551$87,064$64,729$42,596
LT Debt$316,054$307,038$1,257$1,903
Deferred Rev, NC$0$0$140,351$129,923
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$2,509$3,849$4,532$17
Total NC Liab.$318,563$310,887$146,140$131,843
Other Liabilities$0$0$0$0
Cap. Leases$9,681$1,721$2,188$2,614
Total Liabilities$445,114$397,951$210,869$174,439
Equity
Pref Stock$0$0$0$0
Common Stock$5$5$4$3
Retained Earnings-$644,181-$556,239-$392,824-$257,159
AOCI-$373$1,644-$217-$35
Other Equity$870,189$803,260$535,074$377,403
Total Equity$225,640$248,670$142,037$120,212
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$670,754$646,621$352,906$294,651
Net Debt$95,260$21,816-$25,815-$28,726